171 related articles for article (PubMed ID: 22914599)
1. Mutation screening of the APOA5 gene in subjects with coronary artery disease.
Soufi M; Sattler AM; Kurt B; Schaefer JR
J Investig Med; 2012 Oct; 60(7):1015-9. PubMed ID: 22914599
[TBL] [Abstract][Full Text] [Related]
2. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
3. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
[TBL] [Abstract][Full Text] [Related]
4. [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
Liu HK; Zhang SZ; Su ZG; Ma YX; Wang CT
Yi Chuan; 2004 Nov; 26(6):953-6. PubMed ID: 15640132
[TBL] [Abstract][Full Text] [Related]
5. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
[TBL] [Abstract][Full Text] [Related]
6. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
[TBL] [Abstract][Full Text] [Related]
7. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
[TBL] [Abstract][Full Text] [Related]
8. A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency.
Cui G; Li Z; Li R; Huang J; Wang H; Zhang L; Ding H; Wang DW
J Am Coll Cardiol; 2014 Jul; 64(3):267-77. PubMed ID: 25034063
[TBL] [Abstract][Full Text] [Related]
9. Analysis of causal effect of APOA5 variants on premature coronary artery disease.
Wang F; Wang IZ; Ellis S; Archacki S; Barnard J; Hubbard C; Topol EJ; Chen Q; Wang QK
Ann Hum Genet; 2018 Nov; 82(6):437-447. PubMed ID: 30024021
[TBL] [Abstract][Full Text] [Related]
10. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
11. Relationship of APOA5, PPARγ and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood.
Ramakrishnan L; Sachdev HS; Sharma M; Abraham R; Prakash S; Gupta D; Singh Y; Bhaskar S; Sinha S; Chandak GR; Reddy KS; Santosh B
Lipids Health Dis; 2011 May; 10():68. PubMed ID: 21548985
[TBL] [Abstract][Full Text] [Related]
12. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
13. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
[TBL] [Abstract][Full Text] [Related]
14. APOA5 -1131T/C polymorphism is associated with coronary artery disease in a Chinese population: a meta-analysis.
Zhai G; Li M; Zhu C
Clin Chem Lab Med; 2011 Mar; 49(3):535-9. PubMed ID: 21143013
[TBL] [Abstract][Full Text] [Related]
15. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
You Y; Wu YH; Zhang Y; Zhang L; Song Y; Bai W; Li Y; Yu Y; Kou C
BMJ Open; 2018 Jun; 8(6):e020016. PubMed ID: 29866721
[TBL] [Abstract][Full Text] [Related]
16. The influence of the S19W SNP of the APOA5 gene on triglyceride levels in southern Brazil: interactions with the APOE gene, sex and menopause status.
De Andrade FM; Maluf SW; Schuch JB; Voigt F; Barros AC; Lucatelli JF; Hutz MH
Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):584-90. PubMed ID: 20304614
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke.
Can Demirdöğen B; Şahin E; Türkanoğlu Özçelik A; Bek S; Demirkaya Ş; Adali O
Mol Biol Rep; 2012 Dec; 39(12):10459-68. PubMed ID: 23065249
[TBL] [Abstract][Full Text] [Related]
18. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
[TBL] [Abstract][Full Text] [Related]
19. APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.
Wang J; Ban MR; Kennedy BA; Anand S; Yusuf S; Huff MW; Pollex RL; Hegele RA
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):730-7. PubMed ID: 18779834
[TBL] [Abstract][Full Text] [Related]
20. Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease.
Shanker J; Perumal G; Rao VS; Khadrinarasimhiah NB; John S; Hebbagodi S; Mukherjee M; Kakkar VV
Lipids Health Dis; 2008 Sep; 7():33. PubMed ID: 18801202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
